1. How to measure heart rate?

   • C. Ulrich Vogel
   • Christian Wolpert
   • Martin Wehling

   Clinical Trials 05 August 2004 Pages: 461 - 466

   

2. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals

   • Valery V. Bakayev
   • Forozan Mohammadi
   • Ali A. Velayati

   Pharmacogenetics 13 August 2004 Pages: 467 - 471

   

3. Population pharmacokinetic analysis of mirtazapine

   • Katja Grasmäder
   • Petra Louise Verwohlt
   • Marie Luise Rao

   Pharmacokinetics and Disposition 29 July 2004 Pages: 473 - 480

   

4. Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives

   • Ornella Baisini
   • Federica Benini
   • Alberto Lanzini

   Pharmacokinetics and Disposition 28 July 2004 Pages: 481 - 487

   

5. Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study

   • Deborah Layton
   • Lynda V. Wilton
   • Saad A. W. Shakir

   Pharmacoepidemiology and Prescription 22 July 2004 Pages: 489 - 501

6. Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe

   • T. Walley
   • P. Folino-Gallo
   • P. Stephens

   Pharmacoepidemiology and Prescription 13 August 2004 Pages: 503 - 511

7. Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey

   • Lorenza Magliano
   • Andrea Fiorillo
   • The National Mental Health Project Working Group

   Pharmacoepidemiology and Prescription 13 August 2004 Pages: 513 - 522

8. Patterns and correlates of benzodiazepine use in the French general population

   • Rajaa Lagnaoui
   • Fanny Depont
   • Nicholas Moore

   Pharmacoepidemiology and Prescription 28 August 2004 Pages: 523 - 529